These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 18575759)
21. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138. Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085 [TBL] [Abstract][Full Text] [Related]
22. Regulation of the pituitary growth hormone-releasing hormone receptor in ageing male and female LOU rats: new insights into healthy ageing. Veyrat-Durebex C; Alliot J; Gaudreau P J Neuroendocrinol; 2005 Nov; 17(11):691-700. PubMed ID: 16218997 [TBL] [Abstract][Full Text] [Related]
23. Naturally-occurring missense mutations in the human growth hormone-releasing hormone receptor alter ligand binding. Alba M; Salvatori R J Endocrinol; 2005 Sep; 186(3):515-21. PubMed ID: 16135671 [TBL] [Abstract][Full Text] [Related]
25. Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa. Chave HS; Gough AC; Palmer K; Preston SR; Primrose JN Br J Cancer; 2000 Jan; 82(1):124-30. PubMed ID: 10638978 [TBL] [Abstract][Full Text] [Related]
26. Extrapituitary effects of the growth hormone-releasing hormone. Kiaris H; Schally AV; Kalofoutis A Vitam Horm; 2005; 70():1-24. PubMed ID: 15727800 [TBL] [Abstract][Full Text] [Related]
27. Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor. Barabutis N; Siejka A; Schally AV; Block NL; Cai R; Varga JL J Mol Endocrinol; 2010 Feb; 44(2):127-34. PubMed ID: 19897610 [TBL] [Abstract][Full Text] [Related]
28. Biological activities of two porcine growth hormone-releasing hormone receptor isoforms. Hassan HA Arch Biochem Biophys; 2001 Mar; 387(1):20-6. PubMed ID: 11368179 [TBL] [Abstract][Full Text] [Related]
29. A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding. McElvaine AT; Mayo KE Endocrinology; 2006 Apr; 147(4):1884-94. PubMed ID: 16423869 [TBL] [Abstract][Full Text] [Related]
30. Identification of two novel chicken GHRH receptor splice variants: implications for the roles of aspartate 56 in the receptor activation and direct ligand receptor interaction. Wang CY; Wang Y; Kwok AH; Leung FC J Endocrinol; 2007 Dec; 195(3):525-36. PubMed ID: 18000314 [TBL] [Abstract][Full Text] [Related]
31. Regulation of 5'-promoter activity of the rat growth hormone and growth hormone-releasing hormone receptor genes in the MtT/S and MtT/E cells. Nogami H; Hiraoka Y; Inoue K; Aiso S; Hisano S Neuroendocrinology; 2006; 84(1):31-41. PubMed ID: 17090972 [TBL] [Abstract][Full Text] [Related]
32. Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: Novel Therapeutic Approaches. Szabo Z; Juhasz E; Schally AV; Dezso B; Huga S; Hernadi Z; Halmos G; Kiss C Molecules; 2022 Apr; 27(9):. PubMed ID: 35566020 [TBL] [Abstract][Full Text] [Related]
33. Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor. Kiaris H; Chatzistamou I; Schally AV; Halmos G; Varga JL; Koutselini H; Kalofoutis A Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9512-7. PubMed ID: 12867592 [TBL] [Abstract][Full Text] [Related]
34. Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RT-PCR and in situ hybridization. Oka H; Kameya T; Sato Y; Naritaka H; Kawano N J Neurooncol; 1999 Feb; 41(3):197-204. PubMed ID: 10359139 [TBL] [Abstract][Full Text] [Related]
35. Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive. Kővári B; Rusz O; Schally AV; Kahán Z; Cserni G APMIS; 2014 Sep; 122(9):824-31. PubMed ID: 24479854 [TBL] [Abstract][Full Text] [Related]
36. GHRH Receptor Expression in Malignant Mixed Müllerian Tumors: A Potentially Targetable Biopredictor. Mackrides N; Ganjei-Azar P; Perez R; Cui T; Block N; Schally AV; Nadji M Int J Gynecol Pathol; 2016 Mar; 35(2):142-6. PubMed ID: 26535981 [TBL] [Abstract][Full Text] [Related]
37. Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes. Mezey G; Treszl A; Schally AV; Block NL; Vízkeleti L; Juhász A; Klekner A; Nagy J; Balázs M; Halmos G; Bognár L J Cancer Res Clin Oncol; 2014 Oct; 140(10):1641-9. PubMed ID: 24878932 [TBL] [Abstract][Full Text] [Related]
38. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Havt A; Schally AV; Halmos G; Varga JL; Toller GL; Horvath JE; Szepeshazi K; Köster F; Kovitz K; Groot K; Zarandi M; Kanashiro CA Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17424-9. PubMed ID: 16299104 [TBL] [Abstract][Full Text] [Related]
39. Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers. Plonowski A; Schally AV; Busto R; Krupa M; Varga JL; Halmos G Peptides; 2002 Jun; 23(6):1127-33. PubMed ID: 12126741 [TBL] [Abstract][Full Text] [Related]
40. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]